We are pleased to announce the acquisition of a UK Home Office Drug Precursor Licence.
This means that as of May 2019, Carbosynth can possess and supply all Category 1 and Category 2 precursors. The product range includes the newly licenced compounds ANPP and NPP, which are intermediates in the synthesis of pharmaceuticals such as fentanyl and other opioids.
This licence complements the UK Home Office Controlled Drugs Licence which we have held since August 2017, allowing us to sell and export all restricted UK Schedule 1 - 5 compounds. We supply controlled substances of synthetic, semi-synthetic and natural origin.
Opium poppy is a source of opioids such as morphine, codeine and thebaine.
Carbosynth can supply controlled drugs and precursors on a milligram to kilogram scale. For controlled drug inquiries, please contact Dr Ernie Boehm at Ernie.Boehm@carbosynth.com.